Bayer

Bayer

Verified
Global enterprise with core competencies in the Life Science fields of health care and agriculture

Launch date
Employees
Market cap
€55.3b
Net debt
€29.6b
Firm valuation
$94.2b (Public information from 2022)
Leverkusen Nordrhein-Westfalen (HQ)
Corporate Venture Fund: Leaps by Bayer

Financials

Edit
Revenues, earnings & profits over time
EUR2016201720182019202020212022E
Revenues-35.0b39.6b43.5b41.4b43.3b45.4b
% growth--13 %10 %(5 %)5 %5 %
EBITDA-9.3b9.5b11.5b11.5b11.2b12.1b
% EBITDA margin-27 %24 %26 %28 %26 %27 %
Profit-7.3b1.7b4.1b(10.5b)671m4.8b
% profit margin-21 %4 %9 %(25 %)2 %10 %
EV / revenue-2.6x2.3x2.4x2.0x2.0x1.9x
EV / EBITDA-9.7x9.7x9.2x7.4x7.8x7.1x
R&D budget4.8b5.2b5.1b5.6b---
R&D % of revenue-15 %13 %13 %---

Source: Company fillings or news article

  • Edit
DateInvestorsAmountRound
N/ASpinout
N/AN/AIPO
Not yet verified
$7.6bAcquisition
Not yet verified
Total Funding-

Recent News about Bayer

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit

Investments by Bayer

Edit
Zoner.ag
ACQUISITION by Bayer Feb 2016
Algeta
ACQUISITION by Bayer Dec 2013
AgraQuest
ACQUISITION by Bayer Jul 2012
DIREVO Biotech AG
ACQUISITION by Bayer Sep 2008
proPlant
ACQUISITION by Bayer Feb 2016
Monsanto
ACQUISITION by Bayer Jun 2018
View 69 more